Atlas Trials

Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT

Clinical trial NCT03336632 · UNKNOWN

Trial details

NCT number
NCT03336632
Sponsor
Sichuan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Leukemia, AcuteMDS
Start date
2019-01-01
Primary completion
2020-12-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.